Get started
Markets US Stocks Health Technology Medical Specialties

Bellerophon Therapeutics, Inc

BLPH NASDAQ
BLPH
Bellerophon Therapeutics, Inc NASDAQ
See more on advanced chartSee more on advanced chart
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
See more on advanced chartSee more on advanced chart
Overview
Ideas Financials Technicals

BLPH Stock Chart

Ideas

Videos only
5.5 million in volume
BLPH
, 1D
BLPH: 5.5 million in volume

Large volume today, hopefully the momentum continues tomorrow. BIIB announced that it has dosed the first patient in the phase III study — TOPAZ-1. This news is from last week on Friday.

Good swing opportunity
BLPH
, 240
Long
BLPH: Good swing opportunity

Nice swing opportunity on this inverted head and shoulders... let’s squeeze some shorts

think this is gonna break out
BLPH
, 1D
Long
BLPH: think this is gonna break out

Maybe a break out.

Bellerophon - Long Setup
BLPH
, 1D
Long
BLPH: Bellerophon - Long Setup

What I see... + 10 and 20 MA are above 200MA + Edge shape + Upward Support trend line + Consecutive NR3 + NR7 combo on very low volume + Sideway move within channel + Support provided by the 10MA + Merged MACD? - Vol. is very low - Merged MACD - RSI is at 61 What I setup + Long entry above last week's high - Stop at last week's low + Target at high of the...

$BLPH
BLPH
, 1D
Long
BLPH: $BLPH

Nice chart setup. Heading towards $18+

BLPH In Zone. Thinking its going to dump hard! What do you think
BLPH
, 1 Short
BLPH: BLPH In Zone. Thinking its going to dump hard! What do you think
02:00

Very casual thought process on this one. What are your thoughts?

$BLPH: Rockefellers underwater before hitting a 'Home Run'
BLPH
, 1W
Long
BLPH: $BLPH: Rockefellers underwater before hitting a 'Home Run'

NASDAQ:BLPH Venrock Associates IV LP, The Insiders, acquired an additional 1,370,000 Million shares in September . True, price action has been negative, however, fundamentals matter and having a 'whale' as Venrock in the game makes sense for all of us. So, playing tech Fibonacci retracement from the last low around 0.60 cents and sometime in the future to get...

BLPH Bullish
BLPH
, 1D
BLPH: BLPH Bullish

First idea just simple 2 weekish plan to see how i am at predicting

BLPH Oversold with Buying Opportunity 9-17% Potential Targets
BLPH
, 240
BLPH: BLPH Oversold with Buying Opportunity 9-17% Potential Targets

BLPH is well oversold and extended below the longer term moving average. Prior price action and structure provide targets between 9-17%. Caution this is a more volatile security and comes with higher risk.

MACD and RSI great areas! Watching a great move.
BLPH
, D
Long
BLPH: MACD and RSI great areas! Watching a great move.

Move incoming!

BLPH Triangle
BLPH
, D
BLPH: BLPH Triangle

BLPH Triangle .. Watching to see if continues downtrend or bounces off support

heavy tuesday Lurking
BLPH
, D
BLPH: heavy tuesday Lurking

@kubaw $blph charts are fun! nice demand level here but I'm hoping this comes back to low trend line for strong entry point (disclaimer:im a novice trader whos account is currently in the red!)

heavy lurk for tuesday morning
BLPH
, D
Long
BLPH: heavy lurk for tuesday morning

We're at nice demand level now, but I'm hoping it comes down to lowest trend line for a strong entry point

BLPH
BLPH
, D
Long
BLPH: BLPH

Ascending triangle. taking position on the break. My last BLPH swing locked in 20% in 5 days

BLPH Rising Wedge and Triangle
BLPH
, D
BLPH: BLPH Rising Wedge and Triangle

BLPH Rising Wedge and Triangle. Watching for a close above 1.60

BLPH Triangle
BLPH
, D
BLPH: BLPH Triangle

BLPH Triangle - watching for continued coil and breakout

Long - Triangle
BLPH
, D
Long
BLPH: Long - Triangle

BLPH Breakout from Triangle

Triangle
BLPH
, D
Long
BLPH: Triangle

@TechnicalSwings

Show more ideas

Technicals

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —
More financials

Profile

Sector: Health Technology
Industry: Medical Specialties
Bellerophon Therapeutics, Inc. focuses on developing products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline include PH-ILD, PH-COPD and PH-Sarc. The company was founded in 2009 and is headquartered in Warren, NJ.

Breaking news